EMEA (Europe, Middle East and Africa) Transdermal Drug Delivery System Market Report 2017

November 2017 | 118 pages | ID: EA829282916EN
QYResearch

Abstracts

In this report, the EMEA Transdermal Drug Delivery System market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Transdermal Drug Delivery System for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Transdermal Drug Delivery System market competition by top manufacturers/players, with Transdermal Drug Delivery System sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Hisamitsu
• Mylan
• GSK
• Novartis
• Teve (Actavis)
• Johnson & Johnson
• Lohmann
• Teikoku Seiyaku
• Bayer
• Lingrui
• Sanofi
• Qizheng
• Endo
• Huarun 999
• Haw Par
• Nichiban
• Mentholatum Company
• Laboratoires Genevrier

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Fentanyl
• Nitroglycerin
• Estradiol
• Nicotine
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• OTC
• Rx

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Transdermal Drug Delivery System Market Report 2017

1 TRANSDERMAL DRUG DELIVERY SYSTEM OVERVIEW

1.1 Product Overview and Scope of Transdermal Drug Delivery System
1.2 Classification of Transdermal Drug Delivery System
  1.2.1 EMEA Transdermal Drug Delivery System Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Transdermal Drug Delivery System Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Fentanyl
  1.2.4 Nitroglycerin
  1.2.5 Estradiol
  1.2.6 Nicotine
  1.2.7 Other
1.3 EMEA Transdermal Drug Delivery System Market by Application/End Users
  1.3.1 EMEA Transdermal Drug Delivery System Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 OTC
  1.3.3 Rx
1.4 EMEA Transdermal Drug Delivery System Market by Region
  1.4.1 EMEA Transdermal Drug Delivery System Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Transdermal Drug Delivery System (2012-2022)
  1.5.1 EMEA Transdermal Drug Delivery System Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Transdermal Drug Delivery System Revenue and Growth Rate (2012-2022)

2 EMEA TRANSDERMAL DRUG DELIVERY SYSTEM COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Transdermal Drug Delivery System Market Competition by Players/Manufacturers
  2.1.1 EMEA Transdermal Drug Delivery System Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Transdermal Drug Delivery System Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Transdermal Drug Delivery System Sale Price by Players (2012-2017)
2.2 EMEA Transdermal Drug Delivery System (Volume and Value) by Type/Product Category
  2.2.1 EMEA Transdermal Drug Delivery System Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Transdermal Drug Delivery System Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Transdermal Drug Delivery System Sale Price by Type (2012-2017)
2.3 EMEA Transdermal Drug Delivery System (Volume) by Application
2.4 EMEA Transdermal Drug Delivery System (Volume and Value) by Region
  2.4.1 EMEA Transdermal Drug Delivery System Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Transdermal Drug Delivery System Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Transdermal Drug Delivery System Sales Price by Region (2012-2017)

3 EUROPE TRANSDERMAL DRUG DELIVERY SYSTEM (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Transdermal Drug Delivery System Sales and Value (2012-2017)
  3.1.1 Europe Transdermal Drug Delivery System Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Transdermal Drug Delivery System Revenue and Growth Rate (2012-2017)
3.2 Europe Transdermal Drug Delivery System Sales and Market Share by Type
3.3 Europe Transdermal Drug Delivery System Sales and Market Share by Application
3.4 Europe Transdermal Drug Delivery System Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Transdermal Drug Delivery System Sales Volume by Countries (2012-2017)
  3.4.2 Europe Transdermal Drug Delivery System Revenue by Countries (2012-2017)
  3.4.3 Germany Transdermal Drug Delivery System Sales and Growth Rate (2012-2017)
  3.4.4 France Transdermal Drug Delivery System Sales and Growth Rate (2012-2017)
  3.4.5 UK Transdermal Drug Delivery System Sales and Growth Rate (2012-2017)
  3.4.6 Russia Transdermal Drug Delivery System Sales and Growth Rate (2012-2017)
  3.4.7 Italy Transdermal Drug Delivery System Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Transdermal Drug Delivery System Sales and Growth Rate (2012-2017)

4 MIDDLE EAST TRANSDERMAL DRUG DELIVERY SYSTEM (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Transdermal Drug Delivery System Sales and Value (2012-2017)
  4.1.1 Middle East Transdermal Drug Delivery System Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Transdermal Drug Delivery System Revenue and Growth Rate (2012-2017)
4.2 Middle East Transdermal Drug Delivery System Sales and Market Share by Type
4.3 Middle East Transdermal Drug Delivery System Sales and Market Share by Application
4.4 Middle East Transdermal Drug Delivery System Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Transdermal Drug Delivery System Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Transdermal Drug Delivery System Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Transdermal Drug Delivery System Sales and Growth Rate (2012-2017)
  4.4.4 Israel Transdermal Drug Delivery System Sales and Growth Rate (2012-2017)
  4.4.5 UAE Transdermal Drug Delivery System Sales and Growth Rate (2012-2017)
  4.4.6 Iran Transdermal Drug Delivery System Sales and Growth Rate (2012-2017)

5 AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Transdermal Drug Delivery System Sales and Value (2012-2017)
  5.1.1 Africa Transdermal Drug Delivery System Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Transdermal Drug Delivery System Revenue and Growth Rate (2012-2017)
5.2 Africa Transdermal Drug Delivery System Sales and Market Share by Type
5.3 Africa Transdermal Drug Delivery System Sales and Market Share by Application
5.4 Africa Transdermal Drug Delivery System Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Transdermal Drug Delivery System Sales Volume by Countries (2012-2017)
  5.4.2 Africa Transdermal Drug Delivery System Revenue by Countries (2012-2017)
  5.4.3 South Africa Transdermal Drug Delivery System Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Transdermal Drug Delivery System Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Transdermal Drug Delivery System Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Transdermal Drug Delivery System Sales and Growth Rate (2012-2017)

6 EMEA TRANSDERMAL DRUG DELIVERY SYSTEM MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Hisamitsu
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Transdermal Drug Delivery System Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Hisamitsu Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Mylan
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Transdermal Drug Delivery System Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Mylan Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GSK
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Transdermal Drug Delivery System Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GSK Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Novartis
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Transdermal Drug Delivery System Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Novartis Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Teve (Actavis)
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Transdermal Drug Delivery System Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Teve (Actavis) Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Johnson & Johnson
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Transdermal Drug Delivery System Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Johnson & Johnson Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Lohmann
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Transdermal Drug Delivery System Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Lohmann Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Teikoku Seiyaku
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Transdermal Drug Delivery System Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Bayer
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Transdermal Drug Delivery System Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Bayer Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Lingrui
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Transdermal Drug Delivery System Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Lingrui Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Sanofi
6.12 Qizheng
6.13 Endo
6.14 Huarun
6.15 Haw Par
6.16 Nichiban
6.17 Mentholatum Company
6.18 Laboratoires Genevrier

7 TRANSDERMAL DRUG DELIVERY SYSTEM MANUFACTURING COST ANALYSIS

7.1 Transdermal Drug Delivery System Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Transdermal Drug Delivery System

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Transdermal Drug Delivery System Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Transdermal Drug Delivery System Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET FORECAST (2017-2022)

11.1 EMEA Transdermal Drug Delivery System Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Transdermal Drug Delivery System Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Transdermal Drug Delivery System Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Transdermal Drug Delivery System Price and Trend Forecast (2017-2022)
11.2 EMEA Transdermal Drug Delivery System Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Transdermal Drug Delivery System Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Transdermal Drug Delivery System Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Transdermal Drug Delivery System Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Transdermal Drug Delivery System Sales Forecast by Type (2017-2022)
11.7 EMEA Transdermal Drug Delivery System Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Transdermal Drug Delivery System
Figure EMEA Transdermal Drug Delivery System Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Transdermal Drug Delivery System Sales Volume Market Share by Type (Product Category) in 2016
Figure Fentanyl Product Picture
Figure Nitroglycerin Product Picture
Figure Estradiol Product Picture
Figure Nicotine Product Picture
Figure Other Product Picture
Figure EMEA Transdermal Drug Delivery System Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Transdermal Drug Delivery System by Application in 2016
Figure OTC Examples
Table Key Downstream Customer in OTC
Figure Rx Examples
Table Key Downstream Customer in Rx
Figure EMEA Transdermal Drug Delivery System Market Size (Million USD) by Region (2012-2022)
Figure Europe Transdermal Drug Delivery System Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Transdermal Drug Delivery System Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Transdermal Drug Delivery System Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Transdermal Drug Delivery System Revenue (Million USD) Status and Forecast by Countries
Figure Africa Transdermal Drug Delivery System Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Transdermal Drug Delivery System Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Transdermal Drug Delivery System Sales Volume and Growth Rate (2012-2022)
Figure EMEA Transdermal Drug Delivery System Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Transdermal Drug Delivery System Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Transdermal Drug Delivery System Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Transdermal Drug Delivery System Sales Share by Players (2012-2017)
Figure 2016 Transdermal Drug Delivery System Sales Share by Players
Figure 2017 Transdermal Drug Delivery System Sales Share by Players
Figure EMEA Transdermal Drug Delivery System Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Transdermal Drug Delivery System Revenue (Million USD) by Players (2012-2017)
Table EMEA Transdermal Drug Delivery System Revenue Share by Players (2012-2017)
Table 2016 EMEA Transdermal Drug Delivery System Revenue Share by Players
Table 2017 EMEA Transdermal Drug Delivery System Revenue Share by Players
Table EMEA Transdermal Drug Delivery System Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Transdermal Drug Delivery System Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Transdermal Drug Delivery System Sales Share by Type (2012-2017)
Figure Sales Market Share of Transdermal Drug Delivery System by Type (2012-2017)
Figure EMEA Transdermal Drug Delivery System Sales Market Share by Type (2012-2017)
Table EMEA Transdermal Drug Delivery System Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Transdermal Drug Delivery System Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Transdermal Drug Delivery System by Type in 2016
Table EMEA Transdermal Drug Delivery System Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Transdermal Drug Delivery System Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Transdermal Drug Delivery System Sales Share by Application (2012-2017)
Figure Sales Market Share of Transdermal Drug Delivery System by Application (2012-2017)
Figure EMEA Transdermal Drug Delivery System Sales Market Share by Application in 2016
Table EMEA Transdermal Drug Delivery System Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Transdermal Drug Delivery System Sales Share by Region (2012-2017)
Figure Sales Market Share of Transdermal Drug Delivery System by Region (2012-2017)
Figure EMEA Transdermal Drug Delivery System Sales Market Share in 2016
Table EMEA Transdermal Drug Delivery System Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Transdermal Drug Delivery System Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Transdermal Drug Delivery System by Region (2012-2017)
Figure EMEA Transdermal Drug Delivery System Revenue Market Share Regions in 2016
Table EMEA Transdermal Drug Delivery System Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Transdermal Drug Delivery System Revenue and Growth Rate (2012-2017)
Table Europe Transdermal Drug Delivery System Sales (K Units) by Type (2012-2017)
Table Europe Transdermal Drug Delivery System Market Share by Type (2012-2017)
Figure Europe Transdermal Drug Delivery System Market Share by Type in 2016
Table Europe Transdermal Drug Delivery System Sales (K Units) by Application (2012-2017)
Table Europe Transdermal Drug Delivery System Market Share by Application (2012-2017)
Figure Europe Transdermal Drug Delivery System Market Share by Application in 2016
Table Europe Transdermal Drug Delivery System Sales (K Units) by Countries (2012-2017)
Table Europe Transdermal Drug Delivery System Sales Market Share by Countries (2012-2017)
Figure Europe Transdermal Drug Delivery System Sales Market Share by Countries (2012-2017)
Figure Europe Transdermal Drug Delivery System Sales Market Share by Countries in 2016
Table Europe Transdermal Drug Delivery System Revenue (Million USD) by Countries (2012-2017)
Table Europe Transdermal Drug Delivery System Revenue Market Share by Countries (2012-2017)
Figure Europe Transdermal Drug Delivery System Revenue Market Share by Countries (2012-2017)
Figure Europe Transdermal Drug Delivery System Revenue Market Share by Countries in 2016
Figure Germany Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure France Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure UK Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Transdermal Drug Delivery System Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Transdermal Drug Delivery System Sales (K Units) by Type (2012-2017)
Table Middle East Transdermal Drug Delivery System Market Share by Type (2012-2017)
Figure Middle East Transdermal Drug Delivery System Market Share by Type (2012-2017)
Table Middle East Transdermal Drug Delivery System Sales (K Units) by Applications (2012-2017)
Table Middle East Transdermal Drug Delivery System Market Share by Applications (2012-2017)
Figure Middle East Transdermal Drug Delivery System Sales Market Share by Application in 2016
Table Middle East Transdermal Drug Delivery System Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Transdermal Drug Delivery System Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Transdermal Drug Delivery System Sales Volume Market Share by Countries in 2016
Table Middle East Transdermal Drug Delivery System Revenue (Million USD) by Countries (2012-2017)
Table Middle East Transdermal Drug Delivery System Revenue Market Share by Countries (2012-2017)
Figure Middle East Transdermal Drug Delivery System Revenue Market Share by Countries (2012-2017)
Figure Middle East Transdermal Drug Delivery System Revenue Market Share by Countries in 2016
Figure Saudi Arabia Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Transdermal Drug Delivery System Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Transdermal Drug Delivery System Sales (K Units) by Type (2012-2017)
Table Africa Transdermal Drug Delivery System Sales Market Share by Type (2012-2017)
Figure Africa Transdermal Drug Delivery System Sales Market Share by Type (2012-2017)
Figure Africa Transdermal Drug Delivery System Sales Market Share by Type in 2016
Table Africa Transdermal Drug Delivery System Sales (K Units) by Application (2012-2017)
Table Africa Transdermal Drug Delivery System Sales Market Share by Application (2012-2017)
Figure Africa Transdermal Drug Delivery System Sales Market Share by Application (2012-2017)
Table Africa Transdermal Drug Delivery System Sales Volume (K Units) by Countries (2012-2017)
Table Africa Transdermal Drug Delivery System Sales Market Share by Countries (2012-2017)
Figure Africa Transdermal Drug Delivery System Sales Market Share by Countries (2012-2017)
Figure Africa Transdermal Drug Delivery System Sales Market Share by Countries in 2016
Table Africa Transdermal Drug Delivery System Revenue (Million USD) by Countries (2012-2017)
Table Africa Transdermal Drug Delivery System Revenue Market Share by Countries (2012-2017)
Figure Africa Transdermal Drug Delivery System Revenue Market Share by Countries (2012-2017)
Figure Africa Transdermal Drug Delivery System Revenue Market Share by Countries in 2016
Figure South Africa Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Table Hisamitsu Transdermal Drug Delivery System Basic Information List
Table Hisamitsu Transdermal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hisamitsu Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Hisamitsu Transdermal Drug Delivery System Sales Market Share in EMEA (2012-2017)
Figure Hisamitsu Transdermal Drug Delivery System Revenue Market Share in EMEA (2012-2017)
Table Mylan Transdermal Drug Delivery System Basic Information List
Table Mylan Transdermal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mylan Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Mylan Transdermal Drug Delivery System Sales Market Share in EMEA (2012-2017)
Figure Mylan Transdermal Drug Delivery System Revenue Market Share in EMEA (2012-2017)
Table GSK Transdermal Drug Delivery System Basic Information List
Table GSK Transdermal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure GSK Transdermal Drug Delivery System Sales Market Share in EMEA (2012-2017)
Figure GSK Transdermal Drug Delivery System Revenue Market Share in EMEA (2012-2017)
Table Novartis Transdermal Drug Delivery System Basic Information List
Table Novartis Transdermal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis Transdermal Drug Delivery System Sales Market Share in EMEA (2012-2017)
Figure Novartis Transdermal Drug Delivery System Revenue Market Share in EMEA (2012-2017)
Table Teve (Actavis) Transdermal Drug Delivery System Basic Information List
Table Teve (Actavis) Transdermal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teve (Actavis) Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Teve (Actavis) Transdermal Drug Delivery System Sales Market Share in EMEA (2012-2017)
Figure Teve (Actavis) Transdermal Drug Delivery System Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Transdermal Drug Delivery System Basic Information List
Table Johnson & Johnson Transdermal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Johnson & Johnson Transdermal Drug Delivery System Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Transdermal Drug Delivery System Revenue Market Share in EMEA (2012-2017)
Table Lohmann Transdermal Drug Delivery System Basic Information List
Table Lohmann Transdermal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lohmann Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Lohmann Transdermal Drug Delivery System Sales Market Share in EMEA (2012-2017)
Figure Lohmann Transdermal Drug Delivery System Revenue Market Share in EMEA (2012-2017)
Table Teikoku Seiyaku Transdermal Drug Delivery System Basic Information List
Table Teikoku Seiyaku Transdermal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teikoku Seiyaku Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Teikoku Seiyaku Transdermal Drug Delivery System Sales Market Share in EMEA (2012-2017)
Figure Teikoku Seiyaku Transdermal Drug Delivery System Revenue Market Share in EMEA (2012-2017)
Table Bayer Transdermal Drug Delivery System Basic Information List
Table Bayer Transdermal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Bayer Transdermal Drug Delivery System Sales Market Share in EMEA (2012-2017)
Figure Bayer Transdermal Drug Delivery System Revenue Market Share in EMEA (2012-2017)
Table Lingrui Transdermal Drug Delivery System Basic Information List
Table Lingrui Transdermal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lingrui Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Lingrui Transdermal Drug Delivery System Sales Market Share in EMEA (2012-2017)
Figure Lingrui Transdermal Drug Delivery System Revenue Market Share in EMEA (2012-2017)
Table Sanofi Transdermal Drug Delivery System Basic Information List
Table Qizheng Transdermal Drug Delivery System Basic Information List
Table Endo Transdermal Drug Delivery System Basic Information List
Table Huarun 999 Transdermal Drug Delivery System Basic Information List
Table Haw Par Transdermal Drug Delivery System Basic Information List
Table Nichiban Transdermal Drug Delivery System Basic Information List
Table Mentholatum Company Transdermal Drug Delivery System Basic Information List
Table Laboratoires Genevrier Transdermal Drug Delivery System Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Transdermal Drug Delivery System
Figure Manufacturing Process Analysis of Transdermal Drug Delivery System
Figure Transdermal Drug Delivery System Industrial Chain Analysis
Table Raw Materials Sources of Transdermal Drug Delivery System Major Manufacturers in 2016
Table Major Buyers of Transdermal Drug Delivery System
Table Distributors/Traders List
Figure EMEA Transdermal Drug Delivery System Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Transdermal Drug Delivery System Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Transdermal Drug Delivery System Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Transdermal Drug Delivery System Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Transdermal Drug Delivery System Sales Market Share Forecast by Region (2017-2022)
Table EMEA Transdermal Drug Delivery System Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Transdermal Drug Delivery System Revenue Market Share Forecast by Region (2017-2022)
Table Europe Transdermal Drug Delivery System Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Transdermal Drug Delivery System Sales Market Share Forecast by Countries (2017-2022)
Table Europe Transdermal Drug Delivery System Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Transdermal Drug Delivery System Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Transdermal Drug Delivery System Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Transdermal Drug Delivery System Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Transdermal Drug Delivery System Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Transdermal Drug Delivery System Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Transdermal Drug Delivery System Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Transdermal Drug Delivery System Sales Market Share Forecast by Countries (2017-2022)
Table Africa Transdermal Drug Delivery System Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Transdermal Drug Delivery System Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Transdermal Drug Delivery System Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Transdermal Drug Delivery System Sales Market Share Forecast by Type (2017-2022)
Table EMEA Transdermal Drug Delivery System Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Transdermal Drug Delivery System Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources